TickerFactsScreenerDevelopers

Entrada Therapeutics, Inc. (TRDA) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2020: $39.05M2021: $291.06M2022: $45.16M2023: $67.60M2024: $101.21M2025: $90.39M$90.39M
2020Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$90.39M-10.7%
2024$101.21M+49.7%
2023$67.60M+49.7%
2022$45.16M-84.5%
2021$291.06M+645.5%
2020$39.05M—